4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-16-088045
Options or other derivatives
- Chief Scientific Officer acquired 85,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Lewis David L. Chief Scientific Officer | 2016-01-01 | Grant or award · Stock Option | +85,000 | 472,500 | D | ||
Loading xslF345X03/doc4.xml…